Initial Epinephrine Dosage for Refractory Shock
For refractory shock, the initial epinephrine dosage should be 0.1 mcg/kg/min intravenously, titrated to desired clinical effect with a range of 0.1-1.0 mcg/kg/min. 1
Pharmacological Considerations
Epinephrine is a potent vasopressor with both alpha and beta adrenergic effects that can be life-saving in refractory shock when first-line agents have failed. When administering epinephrine:
- Start at the lowest effective dose (0.1 mcg/kg/min) to minimize adverse effects 1
- Titrate carefully in increments of 0.05-0.2 mcg/kg/min every 10-15 minutes 2
- Maximum doses as high as 5 mcg/kg/min may occasionally be necessary in severe cases 1
- FDA-approved dosing range for septic shock is 0.05-2 mcg/kg/min 3
Administration Guidelines
Preparation and Delivery
- Dilute 1 mg (1 mL) of epinephrine in 100 mL of normal saline to create a 10 mcg/mL solution 2
- Administer through a central venous line whenever possible to reduce risk of extravasation 1
- If central access is unavailable, peripheral administration can be used temporarily while obtaining central access 2
- Avoid using veins of the leg in elderly patients or those with occlusive vascular diseases 3
Monitoring Requirements
- Continuous cardiac monitoring is essential
- Frequent blood pressure measurements (every minute if continuous monitoring unavailable)
- Regular assessment of tissue perfusion (capillary refill, urine output, mental status)
- Monitor for signs of digital ischemia due to peripheral vasoconstriction 2
Clinical Considerations
When to Use Epinephrine for Refractory Shock
- After failure of initial fluid resuscitation
- When first-line vasopressors (typically norepinephrine) have failed to restore adequate perfusion
- As a second-line agent in septic shock 1
- As a first-line agent in cardiogenic shock with low cardiac output 1
Potential Adverse Effects
- Tachyarrhythmias and ectopic beats
- Increased myocardial oxygen consumption
- Lactic acidosis (independent of tissue perfusion due to metabolic effects) 1
- Hyperglycemia due to inhibition of insulin and stimulation of gluconeogenesis 1
- Tissue necrosis if extravasation occurs 1
Special Situations
Extravasation Management
- If extravasation occurs, immediately infiltrate the area with phentolamine (0.1-0.2 mg/kg up to 10 mg diluted in 10 mL of 0.9% sodium chloride) 1
- This counteracts dermal vasoconstriction and may prevent tissue necrosis
Beta-Blocker Overdose
- Higher doses of epinephrine may be considered in beta-blocker overdose (Class IIb, LOE C) 1
- IV glucagon (1-2 mg) may also be required in these cases 2
Weaning Considerations
- After hemodynamic stabilization, wean incrementally over time
- Consider decreasing doses every 30 minutes over a 12-24 hour period 3
- Monitor closely for recurrence of hypotension during weaning
Cautions and Contraindications
- Use with caution in patients with coronary artery disease due to increased myocardial oxygen demand 2
- Avoid in uncorrected hypovolemia - ensure adequate fluid resuscitation first 2
- Epinephrine may be less preferable than norepinephrine in cardiogenic shock after myocardial infarction due to higher incidence of refractory shock 4
- High-dose epinephrine may be harmful in asphyxia-related shock (Class III, LOE B) 1
Epinephrine remains a critical agent in the management of refractory shock, but careful dosing, monitoring, and awareness of its metabolic effects are essential for safe and effective use.